S&P 500 7,442.02 −3.21%
Nasdaq 24,464.14 −4.94%
S&P/TSX 35,758.16 −1.60%
Apple 348.04 −0.42%
Nvidia 183.60 −8.26%
Microsoft 537.11 −3.36%
Shopify 196.15 −7.79%
Royal Bank 288.00 −1.56%
CAD/USD 0.7146 +0.08%
LIVE · 11:00 ET
Market ClerkRecap
Thu Nov 5 · markets open2 signals today194 insider buys this week · $438.8MCIRO short report next: Nov 15The week ahead
PC
INSIDER · REGN · REGENERON PHARMACEUTICALS, INC. · DIRECTOR

POON CHRISTINE A

Every open-market transaction filed under this name, Nov 2 to Nov 2.

Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$7.6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell201$971.31$195K−3.7%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell937$970.51$909K−3.7%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell3,203$969.50$3.1M−3.6%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell2,499$968.58$2.4M−3.5%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell772$967.38$747K−3.4%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell218$966.74$211K−3.3%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.